Spondyloepimetaphyseal dysplasia, Camera-Genevieve type

What is Spondyloepimetaphyseal dysplasia, Camera-Genevieve type?

It is a rare syndrome that presents with bone dysplasia and severe developmental delay.

This syndrome is also known as:
Semd, Genevieve Type SEMDG

What gene changes cause Spondyloepimetaphyseal dysplasia, Camera-Genevieve type?

Mutations in the NANS gene are responsible for the syndrome.

The syndrome is inherited in an autosomal recessive pattern.

What are the main symptoms of Spondyloepimetaphyseal dysplasia, Camera-Genevieve type?

The main symptoms of this rare syndrome include severe developmental delay and a number of symptoms associated with skeletal dysplasia. These symptoms include a short statue, premature bone ossification and a number of other related medical issues.

Unique facial features include facial dysmorphism, a prominent forehead, a depressed nasal bridge, a prominent nasal tip and full lips. Platyspondyly (abnormal vertebrae) and abnormal epiphyseal and metaphyseal (observed in the extremes of the long bones) ossification stand for the spondyloepimetaphyseal in the name.

Possible clinical traits/features:
Small epiphyses, Microcephaly, Thick lower lip vermilion, Synophrys, Spondyloepimetaphyseal dysplasia, Coarse facial features, Epicanthus, Long fibula, Flared metaphysis, Metaphyseal irregularity, Flat acetabular roof, Abnormality of the skin, Hirsutism, Short femoral neck, Low anterior hairline, Low posterior hairline, Intellectual disability, Irregular epiphyses, Irregular vertebral endplates, Narrow iliac wings, Muscular hypotonia, Short neck, Posterior scalloping of vertebral bodies, Platyspondyly, Autosomal recessive inheritance, Nystagmus, Abnormality of the pinna, Brachycephaly, Carpal bone hypoplasia, Ataxia, Wide nose

How does someone get tested for Spondyloepimetaphyseal dysplasia, Camera-Genevieve type?

The initial testing for Spondyloepimetaphyseal dysplasia, Camera-Genevieve type can begin with facial analysis screening, through the FDNA Telehealth telegenetics platform, which can identify the key markers of the syndrome and outline the need for further testing. A consultation with a genetic counselor and then a geneticist will follow.

Medizinische Informationen zu Spondyloepimetaphyseal dysplasia, Camera-Genevieve type

Two Pakistani sisters, born to first cousin parents had a spondyloepimetaphyseal dysplasia and mental retardation (Genevieve et al., 2005). Hypotonia, nystagmus and poor vision were noted in the neonatal period in patient 1, and later, development was noted to be delayed. At 8 years she was ataxic, without speech and small. Her face was coarse, she had low anterior and posterior hairlines and her ears were flat and simple. She had synophris and she was hairy over her back and her legs. Her nose was broad, her neck short and when seen again at 11 years the coarsening of the facial features was even more marked. Her sister was similar, but in addition had abnormal pigmentation, along with the Blaschkoid lines. All biochemical tests were negative. An ERG in patient 1 detected an abnormal macular signal, but normal peripheral retina. Skeletal X-rays showed flat vertebral bodies, irregular vertebral plates and posterior scalloping. Metaphyses (with vertical striations) were flared and epiphyses small. Carpal bones were small, the acetabular roofs were flat and the femoral necks were short. Dymeclin, the gene responsible for Dyggve-Melchior-Clausen was normal as was PAPSS2, the gene responsible for SEMD - type Pakistani (see elsewhere).
Van Karnebeek et al. (2016) identified missense or truncating biallelic mutations in NANS in nine individuals from six families with infantile-onset severe developmental delay and skeletal dysplasia. The prenatal history was unremarkable in all patients except for one in whom prenatal hydrocephalus was diagnosed. Body measurements at birth were normal or slightly lower than normal. The main clinical features included shortening of both the trunk and limbs, muscle hypotonia and global developmental delay including moderate-to-severe intellectual disability. Only one patient acquired speech. Seizures were observed in some of the patients. Short stature was present in all adult patients with height ranging from 130 and 150 cm. Facial features included a prominent forehead, mild synophrys, a sunken nasal bridge, a prominent bulbous nasal tip, and full lips. Brain MRI showed perisylvian polymicrogyria, small basal ganglia, and reduced white matter mass in one patient and cerebral atrophy with nonspecific changes in white matter in four other patients. Skeletal X-rays demonstrated premature carpal ossification, platyspondyly, vertebral coronal clefts in childhood, longitudinal metaphyseal striations, irregularity and metaphyseal flaring, short femoral neck and small epiphyses. Patient body fluids showed an elevation in N-acetyl-D-mannosamine levels, and patient-derived fibroblasts had reduced NANS activity and were unable to incorporate sialic acid precursors into sialylated glycoproteins. NANS gene encodes the synthase for N-acetylneuraminic acid (NeuNAc; sialic acid).

* This information is courtesy of the L M D.
If you find a mistake or would like to contribute additional information, please email us at: [email protected]

Erhalten Sie eine schnellere und genauere Genetische Diagnostik!

Mehr als 250,000 Patienten erfolgreich analysiert!
Warten Sie nicht Jahre auf eine Diagnose. Handeln Sie jetzt und sparen Sie wertvolle Zeit.

Los geht's!

"Unser Weg zu einer Diagnose seltener Krankheiten war eine 5 -jährige Reise, die ich nur als Versuch beschreiben kann, einen Roadtrip ohne Karte zu unternehmen. Wir kannten unseren Ausgangspunkt nicht. Wir kannten unser Ziel nicht. Jetzt haben wir Hoffnung. "

Bild

Paula und Bobby
Eltern von Lillie

Was ist FDNA Telehealth?

FDNA Telehealth ist ein führendes Unternehmen für digitale Gesundheit, das einen schnelleren Zugang zu genauen genetischen Analysen bietet.

Mit einer von führenden Genetikern empfohlenen Krankenhaustechnologie verbindet unsere einzigartige Plattform Patienten mit Genexperten, um ihre dringendsten Fragen zu beantworten und eventuelle Bedenken hinsichtlich ihrer Symptome zu klären.

Vorteile von FDNA Telehealth

FDNA-Symbol

Credibility

Unsere Plattform wird derzeit von über 70% der Genetiker verwendet und wurde zur Diagnose von über 250,000 Patienten weltweit eingesetzt.

FDNA-Symbol

Barrierefreiheit

FDNA Telehealth bietet innerhalb von Minuten eine Gesichtsanalyse und ein Screening, gefolgt von einem schnellen Zugang zu genetischen Beratern und Genetikern.

FDNA-Symbol

Benutzerfreundlichkeit

Unser nahtloser Prozess beginnt mit einer ersten Online-Diagnose durch einen genetischen Berater, gefolgt von Konsultationen mit Genetikern und Gentests.

FDNA-Symbol

Genauigkeit & Präzision

Erweiterte Funktionen und Technologien für künstliche Intelligenz (KI) mit einer Genauigkeitsrate von 90% für eine genauere genetische analyse.

FDNA-Symbol

Preis-Leistungs-Verhältnis

Schnellerer Zugang zu genetischen Beratern, Genetikern, Gentests und einer Diagnose. Falls erforderlich, innerhalb von 24 Stunden. Sparen Sie Zeit und Geld.

FDNA-Symbol

Privatsphäre & Sicherheit

Wir garantieren den größtmöglichen Schutz aller Bilder und Patienteninformationen. Ihre Daten sind immer sicher und verschlüsselt.

FDNA Telehealth kann Sie einer Diagnose näher bringen.
Vereinbaren Sie innerhalb von 72 Stunden ein Online-Treffen zur genetischen Beratung!

EspañolDeutschPortuguêsFrançaisEnglish